Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Alzheimer Disease”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02703636
What this trial is testing

NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients.

Who this might be right for
Mild to Moderate Alzheimer's Disease
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)Study completedNCT04735536
What this trial is testing

Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG

Who this might be right for
Alzheimer Disease
Cognition Therapeutics 16
Early research (Phase 1)Ended earlyNCT01028911
What this trial is testing

Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 9
Large-scale testing (Phase 3)Study completedNCT01872598
What this trial is testing

Masitinib in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
AB Science 721
Testing effectiveness (Phase 2)Study completedNCT03828747
What this trial is testing

Semorinemab in Patients With Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 272
Large-scale testing (Phase 3)Study completedNCT00645190
What this trial is testing

A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Xian-Janssen Pharmaceutical Ltd. 215
Post-approval studies (Phase 4)Study completedNCT01122329
What this trial is testing

A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
University of California, Los Angeles 17
Post-approval studies (Phase 4)WithdrawnNCT00375557
What this trial is testing

Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients

Who this might be right for
Alzheimer's DiseaseDementiaBehavioral Symptoms
University of Cincinnati
Early research (Phase 1)Ended earlyNCT02614131
What this trial is testing

LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

Who this might be right for
HealthyAlzheimer's DiseaseMild Cognitive Impairment
Eli Lilly and Company 50
Testing effectiveness (Phase 2)Study completedNCT02580305
What this trial is testing

SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study

Who this might be right for
Alzheimer's Disease
Suven Life Sciences Limited 564
Testing effectiveness (Phase 2)Study completedNCT01397578
What this trial is testing

Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 91
Post-approval studies (Phase 4)Study completedNCT00035204
What this trial is testing

The Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 63
Early research (Phase 1)Study completedNCT01716637
What this trial is testing

Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Life Extension Foundation Inc. 12
Post-approval studies (Phase 4)Study completedNCT00505167
What this trial is testing

Memantine Versus Donepezil in Early Stages of Alzheimer's Disease

Who this might be right for
Dementia, Alzheimer Type
Hospital Miguel Servet 64
Post-approval studies (Phase 4)Study completedNCT01921972
What this trial is testing

The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Charite University, Berlin, Germany 232
Not applicableStudy completedNCT01094145
What this trial is testing

Deep Brain Stimulation (DBS) of the Nucleus Basalis Meynert (NBM) to Treat Cognitive Deficits in Light to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
University of Cologne 6
Early research (Phase 1)Study completedNCT01230853
What this trial is testing

A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study

Who this might be right for
Alzheimer's Disease
Eisai Inc. 80
Large-scale testing (Phase 3)Ended earlyNCT01883648
What this trial is testing

Study to Evaluate Coconut Oil for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
University of South Florida 21
Testing effectiveness (Phase 2)Study completedNCT00443417
What this trial is testing

A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
SK Chemicals Co., Ltd. 188
Very early researchNot Yet RecruitingNCT06836180
What this trial is testing

An Exploratory Study of Near-infrared Light Therapy for Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Xuanwu Hospital, Beijing 40
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation